[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

EMEA (Europe, Middle East and Africa) Nuclear Receptor ROR Gamma Market Report 2017

December 2017 | 111 pages | ID: EA440175DEEEN
QYResearch

US$ 4,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the EMEA Nuclear Receptor ROR Gamma market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Pcs), revenue (Million USD), market share and growth rate of Nuclear Receptor ROR Gamma for these regions, from 2012 to 2022 (forecast)
  • Europe: Germany, France, UK, Russia, Italy and Benelux;
  • Middle East: Saudi Arabia, Israel, UAE and Iran;
  • Africa: South Africa, Nigeria, Egypt and Algeria.
EMEA Nuclear Receptor ROR Gamma market competition by top manufacturers/players, with Nuclear Receptor ROR Gamma sales volume (K Pcs), price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Genfit SA
  • GlaxoSmithKline Plc
  • Aurigene Discovery Technologies Ltd
  • Beijing Hanmi Pharmaceutical Co Ltd
  • Biogen Inc
  • AbbVie Inc
  • Advinus Therapeutics Ltd
  • Brickell Biotech Inc
  • Pfizer Inc
  • Phenex Pharmaceuticals AG
  • Reata Pharmaceuticals Inc
  • Bristol-Myers Squibb Company
  • Celgene Corp
  • Eli Lilly and Company
  • Glenmark Pharmaceuticals Ltd
  • Lead Pharma Holding BV
On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
  • BBI-6000
  • GRC-39815Action
  • R&D Progress
  • GSK-2981278
  • IMU-366
  • INV-17
  • Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
  • Chronic Obstructive Pulmonary Disease
  • Asthma
  • Axial Spondyloarthritis
  • Breast Cancer
  • Others
If you have any special requirements, please let us know and we will offer you the report as you want.
EMEA (Europe, Middle East and Africa) Nuclear Receptor ROR Gamma Market Report 2017

1 NUCLEAR RECEPTOR ROR GAMMA OVERVIEW

1.1 Product Overview and Scope of Nuclear Receptor ROR Gamma
1.2 Classification of Nuclear Receptor ROR Gamma
  1.2.1 EMEA Nuclear Receptor ROR Gamma Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Nuclear Receptor ROR Gamma Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 BBI-6000
  1.2.4 GRC-39815Action
  1.2.5 R&D Progress
  1.2.6 GSK-2981278
  1.2.7 IMU-366
  1.2.8 INV-17
  1.2.9 Others
1.3 EMEA Nuclear Receptor ROR Gamma Market by Application/End Users
  1.3.1 EMEA Nuclear Receptor ROR Gamma Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Chronic Obstructive Pulmonary Disease
  1.3.3 Asthma
  1.3.4 Axial Spondyloarthritis
  1.3.5 Breast Cancer
  1.3.6 Others
1.4 EMEA Nuclear Receptor ROR Gamma Market by Region
  1.4.1 EMEA Nuclear Receptor ROR Gamma Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Nuclear Receptor ROR Gamma (2012-2022)
  1.5.1 EMEA Nuclear Receptor ROR Gamma Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Nuclear Receptor ROR Gamma Revenue and Growth Rate (2012-2022)

2 EMEA NUCLEAR RECEPTOR ROR GAMMA COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Nuclear Receptor ROR Gamma Market Competition by Players/Manufacturers
  2.1.1 EMEA Nuclear Receptor ROR Gamma Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Nuclear Receptor ROR Gamma Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Nuclear Receptor ROR Gamma Sale Price by Players (2012-2017)
2.2 EMEA Nuclear Receptor ROR Gamma (Volume and Value) by Type/Product Category
  2.2.1 EMEA Nuclear Receptor ROR Gamma Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Nuclear Receptor ROR Gamma Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Nuclear Receptor ROR Gamma Sale Price by Type (2012-2017)
2.3 EMEA Nuclear Receptor ROR Gamma (Volume) by Application
2.4 EMEA Nuclear Receptor ROR Gamma (Volume and Value) by Region
  2.4.1 EMEA Nuclear Receptor ROR Gamma Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Nuclear Receptor ROR Gamma Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Nuclear Receptor ROR Gamma Sales Price by Region (2012-2017)

3 EUROPE NUCLEAR RECEPTOR ROR GAMMA (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Nuclear Receptor ROR Gamma Sales and Value (2012-2017)
  3.1.1 Europe Nuclear Receptor ROR Gamma Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Nuclear Receptor ROR Gamma Revenue and Growth Rate (2012-2017)
3.2 Europe Nuclear Receptor ROR Gamma Sales and Market Share by Type
3.3 Europe Nuclear Receptor ROR Gamma Sales and Market Share by Application
3.4 Europe Nuclear Receptor ROR Gamma Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Nuclear Receptor ROR Gamma Sales Volume by Countries (2012-2017)
  3.4.2 Europe Nuclear Receptor ROR Gamma Revenue by Countries (2012-2017)
  3.4.3 Germany Nuclear Receptor ROR Gamma Sales and Growth Rate (2012-2017)
  3.4.4 France Nuclear Receptor ROR Gamma Sales and Growth Rate (2012-2017)
  3.4.5 UK Nuclear Receptor ROR Gamma Sales and Growth Rate (2012-2017)
  3.4.6 Russia Nuclear Receptor ROR Gamma Sales and Growth Rate (2012-2017)
  3.4.7 Italy Nuclear Receptor ROR Gamma Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Nuclear Receptor ROR Gamma Sales and Growth Rate (2012-2017)

4 MIDDLE EAST NUCLEAR RECEPTOR ROR GAMMA (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Nuclear Receptor ROR Gamma Sales and Value (2012-2017)
  4.1.1 Middle East Nuclear Receptor ROR Gamma Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Nuclear Receptor ROR Gamma Revenue and Growth Rate (2012-2017)
4.2 Middle East Nuclear Receptor ROR Gamma Sales and Market Share by Type
4.3 Middle East Nuclear Receptor ROR Gamma Sales and Market Share by Application
4.4 Middle East Nuclear Receptor ROR Gamma Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Nuclear Receptor ROR Gamma Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Nuclear Receptor ROR Gamma Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Nuclear Receptor ROR Gamma Sales and Growth Rate (2012-2017)
  4.4.4 Israel Nuclear Receptor ROR Gamma Sales and Growth Rate (2012-2017)
  4.4.5 UAE Nuclear Receptor ROR Gamma Sales and Growth Rate (2012-2017)
  4.4.6 Iran Nuclear Receptor ROR Gamma Sales and Growth Rate (2012-2017)

5 AFRICA NUCLEAR RECEPTOR ROR GAMMA (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Nuclear Receptor ROR Gamma Sales and Value (2012-2017)
  5.1.1 Africa Nuclear Receptor ROR Gamma Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Nuclear Receptor ROR Gamma Revenue and Growth Rate (2012-2017)
5.2 Africa Nuclear Receptor ROR Gamma Sales and Market Share by Type
5.3 Africa Nuclear Receptor ROR Gamma Sales and Market Share by Application
5.4 Africa Nuclear Receptor ROR Gamma Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Nuclear Receptor ROR Gamma Sales Volume by Countries (2012-2017)
  5.4.2 Africa Nuclear Receptor ROR Gamma Revenue by Countries (2012-2017)
  5.4.3 South Africa Nuclear Receptor ROR Gamma Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Nuclear Receptor ROR Gamma Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Nuclear Receptor ROR Gamma Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Nuclear Receptor ROR Gamma Sales and Growth Rate (2012-2017)

6 EMEA NUCLEAR RECEPTOR ROR GAMMA MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Genfit SA
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Nuclear Receptor ROR Gamma Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Genfit SA Nuclear Receptor ROR Gamma Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 GlaxoSmithKline Plc
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Nuclear Receptor ROR Gamma Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 GlaxoSmithKline Plc Nuclear Receptor ROR Gamma Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Aurigene Discovery Technologies Ltd
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Nuclear Receptor ROR Gamma Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Aurigene Discovery Technologies Ltd Nuclear Receptor ROR Gamma Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Beijing Hanmi Pharmaceutical Co Ltd
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Nuclear Receptor ROR Gamma Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Beijing Hanmi Pharmaceutical Co Ltd Nuclear Receptor ROR Gamma Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Biogen Inc
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Nuclear Receptor ROR Gamma Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Biogen Inc Nuclear Receptor ROR Gamma Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 AbbVie Inc
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Nuclear Receptor ROR Gamma Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 AbbVie Inc Nuclear Receptor ROR Gamma Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Advinus Therapeutics Ltd
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Nuclear Receptor ROR Gamma Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Advinus Therapeutics Ltd Nuclear Receptor ROR Gamma Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Brickell Biotech Inc
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Nuclear Receptor ROR Gamma Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Brickell Biotech Inc Nuclear Receptor ROR Gamma Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Pfizer Inc
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Nuclear Receptor ROR Gamma Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Pfizer Inc Nuclear Receptor ROR Gamma Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Phenex Pharmaceuticals AG
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Nuclear Receptor ROR Gamma Product Type, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Phenex Pharmaceuticals AG Nuclear Receptor ROR Gamma Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Reata Pharmaceuticals Inc
6.12 Bristol-Myers Squibb Company
6.13 Celgene Corp
6.14 Eli Lilly and Company
6.15 Glenmark Pharmaceuticals Ltd
6.16 Lead Pharma Holding BV

7 NUCLEAR RECEPTOR ROR GAMMA MANUFACTURING COST ANALYSIS

7.1 Nuclear Receptor ROR Gamma Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Nuclear Receptor ROR Gamma

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Nuclear Receptor ROR Gamma Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Nuclear Receptor ROR Gamma Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA NUCLEAR RECEPTOR ROR GAMMA MARKET FORECAST (2017-2022)

11.1 EMEA Nuclear Receptor ROR Gamma Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Nuclear Receptor ROR Gamma Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Nuclear Receptor ROR Gamma Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Nuclear Receptor ROR Gamma Price and Trend Forecast (2017-2022)
11.2 EMEA Nuclear Receptor ROR Gamma Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Nuclear Receptor ROR Gamma Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Nuclear Receptor ROR Gamma Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Nuclear Receptor ROR Gamma Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Nuclear Receptor ROR Gamma Sales Forecast by Type (2017-2022)
11.7 EMEA Nuclear Receptor ROR Gamma Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Product Picture of Nuclear Receptor ROR Gamma
Figure EMEA Nuclear Receptor ROR Gamma Sales Volume (K Pcs) by Type (2012-2022)
Figure EMEA Nuclear Receptor ROR Gamma Sales Volume Market Share by Type (Product Category) in 2016
Figure BBI-6000 Product Picture
Figure GRC-39815Action Product Picture
Figure R&D Progress Product Picture
Figure GSK-2981278 Product Picture
Figure IMU-366 Product Picture
Figure INV-17 Product Picture
Figure Others Product Picture
Figure EMEA Nuclear Receptor ROR Gamma Sales Volume (K Pcs) by Application (2012-2022)
Figure EMEA Sales Market Share of Nuclear Receptor ROR Gamma by Application in 2016
Figure Chronic Obstructive Pulmonary Disease Examples
Table Key Downstream Customer in Chronic Obstructive Pulmonary Disease
Figure Asthma Examples
Table Key Downstream Customer in Asthma
Figure Axial Spondyloarthritis Examples
Table Key Downstream Customer in Axial Spondyloarthritis
Figure Breast Cancer Examples
Table Key Downstream Customer in Breast Cancer
Figure Others Examples
Table Key Downstream Customer in Others
Figure EMEA Nuclear Receptor ROR Gamma Market Size (Million USD) by Region (2012-2022)
Figure Europe Nuclear Receptor ROR Gamma Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Nuclear Receptor ROR Gamma Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Nuclear Receptor ROR Gamma Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Nuclear Receptor ROR Gamma Revenue (Million USD) Status and Forecast by Countries
Figure Africa Nuclear Receptor ROR Gamma Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Nuclear Receptor ROR Gamma Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Nuclear Receptor ROR Gamma Sales Volume and Growth Rate (2012-2022)
Figure EMEA Nuclear Receptor ROR Gamma Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Nuclear Receptor ROR Gamma Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table EMEA Nuclear Receptor ROR Gamma Sales Volume (K Pcs) of Major Players (2012-2017)
Table EMEA Nuclear Receptor ROR Gamma Sales Share by Players (2012-2017)
Figure 2016 Nuclear Receptor ROR Gamma Sales Share by Players
Figure 2017 Nuclear Receptor ROR Gamma Sales Share by Players
Figure EMEA Nuclear Receptor ROR Gamma Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Nuclear Receptor ROR Gamma Revenue (Million USD) by Players (2012-2017)
Table EMEA Nuclear Receptor ROR Gamma Revenue Share by Players (2012-2017)
Table 2016 EMEA Nuclear Receptor ROR Gamma Revenue Share by Players
Table 2017 EMEA Nuclear Receptor ROR Gamma Revenue Share by Players
Table EMEA Nuclear Receptor ROR Gamma Sale Price (USD/Pcs) by Players (2012-2017)
Table EMEA Nuclear Receptor ROR Gamma Sales (K Pcs) and Market Share by Type (2012-2017)
Table EMEA Nuclear Receptor ROR Gamma Sales Share by Type (2012-2017)
Figure Sales Market Share of Nuclear Receptor ROR Gamma by Type (2012-2017)
Figure EMEA Nuclear Receptor ROR Gamma Sales Market Share by Type (2012-2017)
Table EMEA Nuclear Receptor ROR Gamma Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Nuclear Receptor ROR Gamma Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Nuclear Receptor ROR Gamma by Type in 2016
Table EMEA Nuclear Receptor ROR Gamma Sale Price (USD/Pcs) by Type (2012-2017)
Table EMEA Nuclear Receptor ROR Gamma Sales (K Pcs) and Market Share by Application (2012-2017)
Table EMEA Nuclear Receptor ROR Gamma Sales Share by Application (2012-2017)
Figure Sales Market Share of Nuclear Receptor ROR Gamma by Application (2012-2017)
Figure EMEA Nuclear Receptor ROR Gamma Sales Market Share by Application in 2016
Table EMEA Nuclear Receptor ROR Gamma Sales (K Pcs) and Market Share by Region (2012-2017)
Table EMEA Nuclear Receptor ROR Gamma Sales Share by Region (2012-2017)
Figure Sales Market Share of Nuclear Receptor ROR Gamma by Region (2012-2017)
Figure EMEA Nuclear Receptor ROR Gamma Sales Market Share in 2016
Table EMEA Nuclear Receptor ROR Gamma Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Nuclear Receptor ROR Gamma Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Nuclear Receptor ROR Gamma by Region (2012-2017)
Figure EMEA Nuclear Receptor ROR Gamma Revenue Market Share Regions in 2016
Table EMEA Nuclear Receptor ROR Gamma Sales Price (USD/Pcs) by Region (2012-2017)
Figure Europe Nuclear Receptor ROR Gamma Sales (K Pcs) and Growth Rate (2012-2017)
Figure Europe Nuclear Receptor ROR Gamma Revenue and Growth Rate (2012-2017)
Table Europe Nuclear Receptor ROR Gamma Sales (K Pcs) by Type (2012-2017)
Table Europe Nuclear Receptor ROR Gamma Market Share by Type (2012-2017)
Figure Europe Nuclear Receptor ROR Gamma Market Share by Type in 2016
Table Europe Nuclear Receptor ROR Gamma Sales (K Pcs) by Application (2012-2017)
Table Europe Nuclear Receptor ROR Gamma Market Share by Application (2012-2017)
Figure Europe Nuclear Receptor ROR Gamma Market Share by Application in 2016
Table Europe Nuclear Receptor ROR Gamma Sales (K Pcs) by Countries (2012-2017)
Table Europe Nuclear Receptor ROR Gamma Sales Market Share by Countries (2012-2017)
Figure Europe Nuclear Receptor ROR Gamma Sales Market Share by Countries (2012-2017)
Figure Europe Nuclear Receptor ROR Gamma Sales Market Share by Countries in 2016
Table Europe Nuclear Receptor ROR Gamma Revenue (Million USD) by Countries (2012-2017)
Table Europe Nuclear Receptor ROR Gamma Revenue Market Share by Countries (2012-2017)
Figure Europe Nuclear Receptor ROR Gamma Revenue Market Share by Countries (2012-2017)
Figure Europe Nuclear Receptor ROR Gamma Revenue Market Share by Countries in 2016
Figure Germany Nuclear Receptor ROR Gamma Sales (K Pcs) and Growth Rate (2012-2017)
Figure France Nuclear Receptor ROR Gamma Sales (K Pcs) and Growth Rate (2012-2017)
Figure UK Nuclear Receptor ROR Gamma Sales (K Pcs) and Growth Rate (2012-2017)
Figure Russia Nuclear Receptor ROR Gamma Sales (K Pcs) and Growth Rate (2012-2017)
Figure Italy Nuclear Receptor ROR Gamma Sales (K Pcs) and Growth Rate (2012-2017)
Figure Benelux Nuclear Receptor ROR Gamma Sales (K Pcs) and Growth Rate (2012-2017)
Figure Middle East Nuclear Receptor ROR Gamma Sales (K Pcs) and Growth Rate (2012-2017)
Figure Middle East Nuclear Receptor ROR Gamma Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Nuclear Receptor ROR Gamma Sales (K Pcs) by Type (2012-2017)
Table Middle East Nuclear Receptor ROR Gamma Market Share by Type (2012-2017)
Figure Middle East Nuclear Receptor ROR Gamma Market Share by Type (2012-2017)
Table Middle East Nuclear Receptor ROR Gamma Sales (K Pcs) by Applications (2012-2017)
Table Middle East Nuclear Receptor ROR Gamma Market Share by Applications (2012-2017)
Figure Middle East Nuclear Receptor ROR Gamma Sales Market Share by Application in 2016
Table Middle East Nuclear Receptor ROR Gamma Sales Volume (K Pcs) by Countries (2012-2017)
Table Middle East Nuclear Receptor ROR Gamma Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Nuclear Receptor ROR Gamma Sales Volume Market Share by Countries in 2016
Table Middle East Nuclear Receptor ROR Gamma Revenue (Million USD) by Countries (2012-2017)
Table Middle East Nuclear Receptor ROR Gamma Revenue Market Share by Countries (2012-2017)
Figure Middle East Nuclear Receptor ROR Gamma Revenue Market Share by Countries (2012-2017)
Figure Middle East Nuclear Receptor ROR Gamma Revenue Market Share by Countries in 2016
Figure Saudi Arabia Nuclear Receptor ROR Gamma Sales (K Pcs) and Growth Rate (2012-2017)
Figure Israel Nuclear Receptor ROR Gamma Sales (K Pcs) and Growth Rate (2012-2017)
Figure UAE Nuclear Receptor ROR Gamma Sales (K Pcs) and Growth Rate (2012-2017)
Figure Iran Nuclear Receptor ROR Gamma Sales (K Pcs) and Growth Rate (2012-2017)
Figure Africa Nuclear Receptor ROR Gamma Sales (K Pcs) and Growth Rate (2012-2017)
Figure Africa Nuclear Receptor ROR Gamma Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Nuclear Receptor ROR Gamma Sales (K Pcs) by Type (2012-2017)
Table Africa Nuclear Receptor ROR Gamma Sales Market Share by Type (2012-2017)
Figure Africa Nuclear Receptor ROR Gamma Sales Market Share by Type (2012-2017)
Figure Africa Nuclear Receptor ROR Gamma Sales Market Share by Type in 2016
Table Africa Nuclear Receptor ROR Gamma Sales (K Pcs) by Application (2012-2017)
Table Africa Nuclear Receptor ROR Gamma Sales Market Share by Application (2012-2017)
Figure Africa Nuclear Receptor ROR Gamma Sales Market Share by Application (2012-2017)
Table Africa Nuclear Receptor ROR Gamma Sales Volume (K Pcs) by Countries (2012-2017)
Table Africa Nuclear Receptor ROR Gamma Sales Market Share by Countries (2012-2017)
Figure Africa Nuclear Receptor ROR Gamma Sales Market Share by Countries (2012-2017)
Figure Africa Nuclear Receptor ROR Gamma Sales Market Share by Countries in 2016
Table Africa Nuclear Receptor ROR Gamma Revenue (Million USD) by Countries (2012-2017)
Table Africa Nuclear Receptor ROR Gamma Revenue Market Share by Countries (2012-2017)
Figure Africa Nuclear Receptor ROR Gamma Revenue Market Share by Countries (2012-2017)
Figure Africa Nuclear Receptor ROR Gamma Revenue Market Share by Countries in 2016
Figure South Africa Nuclear Receptor ROR Gamma Sales (K Pcs) and Growth Rate (2012-2017)
Figure Nigeria Nuclear Receptor ROR Gamma Sales (K Pcs) and Growth Rate (2012-2017)
Figure Egypt Nuclear Receptor ROR Gamma Sales (K Pcs) and Growth Rate (2012-2017)
Figure Algeria Nuclear Receptor ROR Gamma Sales (K Pcs) and Growth Rate (2012-2017)
Table Genfit SA Nuclear Receptor ROR Gamma Basic Information List
Table Genfit SA Nuclear Receptor ROR Gamma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Genfit SA Nuclear Receptor ROR Gamma Sales (K Pcs) and Growth Rate (2012-2017)
Figure Genfit SA Nuclear Receptor ROR Gamma Sales Market Share in EMEA (2012-2017)
Figure Genfit SA Nuclear Receptor ROR Gamma Revenue Market Share in EMEA (2012-2017)
Table GlaxoSmithKline Plc Nuclear Receptor ROR Gamma Basic Information List
Table GlaxoSmithKline Plc Nuclear Receptor ROR Gamma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure GlaxoSmithKline Plc Nuclear Receptor ROR Gamma Sales (K Pcs) and Growth Rate (2012-2017)
Figure GlaxoSmithKline Plc Nuclear Receptor ROR Gamma Sales Market Share in EMEA (2012-2017)
Figure GlaxoSmithKline Plc Nuclear Receptor ROR Gamma Revenue Market Share in EMEA (2012-2017)
Table Aurigene Discovery Technologies Ltd Nuclear Receptor ROR Gamma Basic Information List
Table Aurigene Discovery Technologies Ltd Nuclear Receptor ROR Gamma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Aurigene Discovery Technologies Ltd Nuclear Receptor ROR Gamma Sales (K Pcs) and Growth Rate (2012-2017)
Figure Aurigene Discovery Technologies Ltd Nuclear Receptor ROR Gamma Sales Market Share in EMEA (2012-2017)
Figure Aurigene Discovery Technologies Ltd Nuclear Receptor ROR Gamma Revenue Market Share in EMEA (2012-2017)
Table Beijing Hanmi Pharmaceutical Co Ltd Nuclear Receptor ROR Gamma Basic Information List
Table Beijing Hanmi Pharmaceutical Co Ltd Nuclear Receptor ROR Gamma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Beijing Hanmi Pharmaceutical Co Ltd Nuclear Receptor ROR Gamma Sales (K Pcs) and Growth Rate (2012-2017)
Figure Beijing Hanmi Pharmaceutical Co Ltd Nuclear Receptor ROR Gamma Sales Market Share in EMEA (2012-2017)
Figure Beijing Hanmi Pharmaceutical Co Ltd Nuclear Receptor ROR Gamma Revenue Market Share in EMEA (2012-2017)
Table Biogen Inc Nuclear Receptor ROR Gamma Basic Information List
Table Biogen Inc Nuclear Receptor ROR Gamma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Biogen Inc Nuclear Receptor ROR Gamma Sales (K Pcs) and Growth Rate (2012-2017)
Figure Biogen Inc Nuclear Receptor ROR Gamma Sales Market Share in EMEA (2012-2017)
Figure Biogen Inc Nuclear Receptor ROR Gamma Revenue Market Share in EMEA (2012-2017)
Table AbbVie Inc Nuclear Receptor ROR Gamma Basic Information List
Table AbbVie Inc Nuclear Receptor ROR Gamma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure AbbVie Inc Nuclear Receptor ROR Gamma Sales (K Pcs) and Growth Rate (2012-2017)
Figure AbbVie Inc Nuclear Receptor ROR Gamma Sales Market Share in EMEA (2012-2017)
Figure AbbVie Inc Nuclear Receptor ROR Gamma Revenue Market Share in EMEA (2012-2017)
Table Advinus Therapeutics Ltd Nuclear Receptor ROR Gamma Basic Information List
Table Advinus Therapeutics Ltd Nuclear Receptor ROR Gamma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Advinus Therapeutics Ltd Nuclear Receptor ROR Gamma Sales (K Pcs) and Growth Rate (2012-2017)
Figure Advinus Therapeutics Ltd Nuclear Receptor ROR Gamma Sales Market Share in EMEA (2012-2017)
Figure Advinus Therapeutics Ltd Nuclear Receptor ROR Gamma Revenue Market Share in EMEA (2012-2017)
Table Brickell Biotech Inc Nuclear Receptor ROR Gamma Basic Information List
Table Brickell Biotech Inc Nuclear Receptor ROR Gamma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Brickell Biotech Inc Nuclear Receptor ROR Gamma Sales (K Pcs) and Growth Rate (2012-2017)
Figure Brickell Biotech Inc Nuclear Receptor ROR Gamma Sales Market Share in EMEA (2012-2017)
Figure Brickell Biotech Inc Nuclear Receptor ROR Gamma Revenue Market Share in EMEA (2012-2017)
Table Pfizer Inc Nuclear Receptor ROR Gamma Basic Information List
Table Pfizer Inc Nuclear Receptor ROR Gamma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Pfizer Inc Nuclear Receptor ROR Gamma Sales (K Pcs) and Growth Rate (2012-2017)
Figure Pfizer Inc Nuclear Receptor ROR Gamma Sales Market Share in EMEA (2012-2017)
Figure Pfizer Inc Nuclear Receptor ROR Gamma Revenue Market Share in EMEA (2012-2017)
Table Phenex Pharmaceuticals AG Nuclear Receptor ROR Gamma Basic Information List
Table Phenex Pharmaceuticals AG Nuclear Receptor ROR Gamma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Phenex Pharmaceuticals AG Nuclear Receptor ROR Gamma Sales (K Pcs) and Growth Rate (2012-2017)
Figure Phenex Pharmaceuticals AG Nuclear Receptor ROR Gamma Sales Market Share in EMEA (2012-2017)
Figure Phenex Pharmaceuticals AG Nuclear Receptor ROR Gamma Revenue Market Share in EMEA (2012-2017)
Table Reata Pharmaceuticals Inc Nuclear Receptor ROR Gamma Basic Information List
Table Bristol-Myers Squibb Company Nuclear Receptor ROR Gamma Basic Information List
Table Celgene Corp Nuclear Receptor ROR Gamma Basic Information List
Table Eli Lilly and Company Nuclear Receptor ROR Gamma Basic Information List
Table Glenmark Pharmaceuticals Ltd Nuclear Receptor ROR Gamma Basic Information List
Table Lead Pharma Holding BV Nuclear Receptor ROR Gamma Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Nuclear Receptor ROR Gamma
Figure Manufacturing Process Analysis of Nuclear Receptor ROR Gamma
Figure Nuclear Receptor ROR Gamma Industrial Chain Analysis
Table Raw Materials Sources of Nuclear Receptor ROR Gamma Major Manufacturers in 2016
Table Major Buyers of Nuclear Receptor ROR Gamma
Table Distributors/Traders List
Figure EMEA Nuclear Receptor ROR Gamma Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure EMEA Nuclear Receptor ROR Gamma Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Nuclear Receptor ROR Gamma Price (USD/Pcs) and Trend Forecast (2017-2022)
Table EMEA Nuclear Receptor ROR Gamma Sales (K Pcs) Forecast by Region (2017-2022)
Figure EMEA Nuclear Receptor ROR Gamma Sales Market Share Forecast by Region (2017-2022)
Table EMEA Nuclear Receptor ROR Gamma Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Nuclear Receptor ROR Gamma Revenue Market Share Forecast by Region (2017-2022)
Table Europe Nuclear Receptor ROR Gamma Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Europe Nuclear Receptor ROR Gamma Sales Market Share Forecast by Countries (2017-2022)
Table Europe Nuclear Receptor ROR Gamma Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Nuclear Receptor ROR Gamma Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Nuclear Receptor ROR Gamma Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Middle East Nuclear Receptor ROR Gamma Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Nuclear Receptor ROR Gamma Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Nuclear Receptor ROR Gamma Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Nuclear Receptor ROR Gamma Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Africa Nuclear Receptor ROR Gamma Sales Market Share Forecast by Countries (2017-2022)
Table Africa Nuclear Receptor ROR Gamma Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Nuclear Receptor ROR Gamma Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Nuclear Receptor ROR Gamma Sales (K Pcs) Forecast by Type (2017-2022)
Figure EMEA Nuclear Receptor ROR Gamma Sales Market Share Forecast by Type (2017-2022)
Table EMEA Nuclear Receptor ROR Gamma Sales (K Pcs) Forecast by Application (2017-2022)
Figure EMEA Nuclear Receptor ROR Gamma Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


More Publications